Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.
However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Humana (NYSE:HUM) and the best and worst performers in the health insurance providers industry.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
NRG Energy Inc leads S&P 500's 2024 leaderboard with 70% YTD gain. Palantir follows with 64% surge, only stock from Cathie Wood's ARK funds in top performers.
The Ninth Circuit affirmed a decision denying the FTC's application to block Microsoft's acquisition of Activision Blizzard. The FTC dropped the case and Trump's personnel changes may impact future tech regulation and antitrust enforcement.
The Federal Trade Commission voted 3-0 Thursday to dismiss a lawsuit against PepsiCo Inc. that accused the beverage giant of offering preferential pricing to major retailers, marking a significant shift from Biden-era corporate scrutiny under the new Trump administration.
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
US healthcare stocks came under pressure after CMS said it would expand Medicare Advantage audits and partner with the HHS Inspector General to recover past overpayments.
Health care stocks are tanking in Wednesday's extended trading after CMS announced a significant expansion of its auditing efforts for Medicare Advantage (MA) plans.
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
Stocks had a strong week on a potential U.S.-China trade deal and cooler inflation data, but volatility may remain as investors shift focus to tax cuts
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
